Application of LC–NMR for the study of the volatile metabolite of MK-0869, a substance P receptor antagonist
- 20 November 2002
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 30 (5) , 1431-1440
- https://doi.org/10.1016/s0731-7085(01)00715-4
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Use of an NK1 Receptor Antagonist to Prevent Delayed Emesis After CisplatinJNCI Journal of the National Cancer Institute, 1997
- Directly Coupled HPLC-NMR and Its Application to Drug MetabolismDrug Metabolism Reviews, 1997
- Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferretsNeuropharmacology, 1996
- 2(S)-((3,5-Bis(trifluoromethyl)benzyl)oxy)-3(S)-phenyl-4-((3-oxo-1,2,4-triazol- 5-yl)methyl)morpholine (1): A Potent, Orally Active, Morpholine-Based Human Neurokinin-1 Receptor AntagonistJournal of Medicinal Chemistry, 1996
- Enantioselective inhibition of ampomorphine-induced emesis in the ferret by the neurokinin1 receptor antagonist CP-99,994Neuropharmacology, 1994
- Anti-emetic profile of a non-peptide neurokinin NK1 receptor antagonist, CP-99,994, in ferretsEuropean Journal of Pharmacology, 1993
- Neurotransmitter functions of mammalian tachykinins.Physiological Reviews, 1993
- Tachykinin receptors and tachykinin receptor antagonistsJournal of Autonomic Pharmacology, 1993
- Neuropharmacology of emesis induced by anti-cancer therapyTrends in Pharmacological Sciences, 1988
- An unidentified depressor substance in certain tissue extractsThe Journal of Physiology, 1931